We are live on !
Find out more
180 Wealth Advisors Portfolio holdings
AUM
$997M
Turnover
12.62%
1-Year Est. Return
47.84%
This Fund
S&P 500
This Quarter Est. Return
+22.12%
1 Year Est. Return
+47.84%
3 Year Est. Return
+135.74%
5 Year Est. Return
+171.8%
10 Year Est. Return
–
AUM
$997M
AUM Growth
+$118M
(+13%)
Cap. Flow
+$8.08M
Cap. Flow % of AUM
Cap. Flow %
0.81%
Top 10 Holdings %
Top 10 Hldgs %
22.96%
Holding
515
New
43
Increased
193
Reduced
240
Closed
22
Avg Time Held
Equity + Options
3.8
years
Top 10 Avg Time Held
Equity + Options
3.3
years
Top 20 Avg Time Held
Equity + Options
3.7
years
Avg Time Held Equity only
3.8
years
Top 10 Avg Time Held Equity only
3.3
years
Top 20 Avg Time Held Equity only
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$3.86M |
| 2 |
Bunge Global
BG
|
+$3.23M |
| 3 |
MannKind Corp
MNKD
|
+$2.17M |
| 4 |
Hycroft Mining Holding Corp
HYMC
|
+$2.08M |
| 5 |
Valero Energy
VLO
|
+$1.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$3.97M |
| 2 |
Intel
INTC
|
+$3.32M |
| 3 |
Medtronic
MDT
|
+$2.41M |
| 4 |
Goldman Sachs
GS
|
+$1.08M |
| 5 |
NVIDIA
NVDA
|
+$1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.63% |
| 2 | Miscellaneous | 28.57% |
| 3 | Healthcare | 8.36% |
| 4 | Consumer Discretionary | 6.88% |
| 5 | Industrials | 6.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
PVH
PVH
$3.91B
| $800K | 0.08% |
10,771
-472
| -4% | -$40.4K |
2024 Q4
6 quarters
|
|
227
Incyte
INCY
$22.9B
| $799K | 0.08% |
7,045
+168
| +2% | +$16.7K |
2020 Q4
22 quarters
|
|
228
Crown Holdings
CCK
$12.4B
| $799K | 0.08% |
7,141
-329
| -4% | -$33.2K |
2025 Q4
2 quarters
|
|
229
Vanguard Morningstar Value ETF
VTV
$191B
| $790K | 0.08% |
3,624
+1
| +0% | +$209 |
2017 Q4
34 quarters
|
|
230
Kinross Gold
KGC
$28.5B
| $789K | 0.08% |
33,404
+2,025
| +6% | +$59.5K |
2022 Q3
15 quarters
|
|
231
DigitalOcean
DOCN
$11.6B
| $788K | 0.08% |
5,020
-357
| -7% | -$48.3K |
2025 Q3
3 quarters
|
|
232
Shopify
SHOP
$218B
| $788K | 0.08% |
6,902
+298
| +5% | +$34K |
2024 Q2
8 quarters
|
|
233
General Mills
GIS
$17.7B
| $786K | 0.08% |
22,574
+5,359
| +31% | +$185K |
2017 Q4
34 quarters
|
|
|
234
Medtronic
MDT
$121B
| $778K | 0.08% |
9,951
-29,822
| -75% | -$2.41M |
2017 Q4
34 quarters
|
|
235
iShares TIPS Bond ETF
TIP
$14.4B
| $777K | 0.08% |
7,103
-3,044
| -30% | -$337K |
2017 Q4
34 quarters
|
|
236
lululemon athletica
LULU
$11.2B
| $769K | 0.08% |
6,734
+1,477
| +28% | +$197K |
2019 Q1
29 quarters
|
|
237
Altria Group
MO
$125B
| $758K | 0.08% |
10,539
+12
| +0.1% | +$838 |
2017 Q4
34 quarters
|
|
238
Northrop Grumman
NOC
$73.9B
| $755K | 0.08% |
1,483
+183
| +14% | +$106K |
2019 Q3
27 quarters
|
|
239
Vanguard Total International Stock ETF
VXUS
$161B
| $748K | 0.08% |
8,747
-3
| -0% | -$251 |
2020 Q4
22 quarters
|
|
240
Elanco Animal Health
ELAN
$11.8B
| $734K | 0.07% |
29,840
-576
| -2% | -$13.3K |
2023 Q1
13 quarters
|
|
241
TJX Companies
TJX
$162B
| $727K | 0.07% |
4,797
-66
| -1% | -$10.4K |
2017 Q4
34 quarters
|
|
242
State Street SPDR S&P 500 ETF Trust
SPY
$806B
| $724K | 0.07% |
970
-119
| -11% | -$86.3K |
2020 Q2
24 quarters
|
|
243
Global X US Infrastructure Development ETF
PAVE
$13.5B
| $716K | 0.07% |
12,148
+4,470
| +58% | +$251K |
2025 Q4
2 quarters
|
|
244
iShares MBS ETF
MBB
$35.9B
| $711K | 0.07% |
7,527
-146
| -2% | -$13.8K |
2017 Q4
34 quarters
|
|
245
American Express
AXP
$212B
| $711K | 0.07% |
2,102
-36
| -2% | -$11.5K |
2022 Q3
15 quarters
|
|
246
Recursion Pharmaceuticals
RXRX
$1.86B
| $699K | 0.07% |
190,562
+20,880
| +12% | +$69.5K |
2024 Q2
8 quarters
|
|
247
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
$48.8B
| $696K | 0.07% |
15,686
+1,866
| +14% | +$79.8K |
2025 Q2
4 quarters
|
|
248
Abercrombie & Fitch
ANF
$6.5B
| $695K | 0.07% |
7,723
-284
| -4% | -$24.1K |
2025 Q2
4 quarters
|
|
249
Coca-Cola
KO
$404B
| $687K | 0.07% |
8,450
+251
| +3% | +$19.8K |
2017 Q4
34 quarters
|
|
250
Coupang
CPNG
$25.7B
| $681K | 0.07% |
39,230
+3,668
| +10% | +$66.2K |
2021 Q3
19 quarters
|
|
Similar funds
180 Wealth Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, 180 Wealth Advisors held 515 positions worth $997M, up 13% from $880M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
180 Wealth Advisors's Q2 2026 filing shows 43 new, 193 increased, 240 reduced and 22 closed positions. Its largest new stake was AstraZeneca: 20,498 shares worth $3.89M. The largest sale was Target, an estimated $3.97M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- 180 Wealth Advisors's largest Q2 2026 buy was AstraZeneca: 20,498 shares worth $3.89M.
- 180 Wealth Advisors added most to MannKind Corp in Q2 2026, an estimated $2.17M increase.
- 180 Wealth Advisors's biggest Q2 2026 reduction was Intel, cutting an estimated $3.32M.
- 180 Wealth Advisors fully exited Target in Q2 2026, selling an estimated $3.97M.
- 180 Wealth Advisors's ten largest holdings make up 23% of its $997M portfolio in Q2 2026.
- 180 Wealth Advisors opened 43 new positions and closed 22 in Q2 2026.
- 180 Wealth Advisors's portfolio value rose 13% quarter-over-quarter to $997M.
Based on 180 Wealth Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.